Advice
Following an abbreviated submission
Formoterol inhalation powder (Easyhaler® Formoterol) is accepted for use within NHS Scotland for the treatment of asthma in patients treated with inhaled corticosteroids and who also require a long-acting beta2-agonist in accordance with current treatment guidelines; and for the relief of reversible airways obstruction in patients with chronic obstructive pulmonary disease (COPD) and requiring long-term bronchodilator therapy.
It should be used in patients for whom formoterol is an appropriate choice of long-acting beta2-agonist and a dry powder inhaler is an appropriate delivery device. It costs less than other inhalers delivering similar doses of formoterol.
Download detailed advice31KB (PDF)
Medicine details
- Medicine name:
- formoterol 12 micrograms metered dose inhaler (Easyhaler)
- SMC ID:
- 375/07
- Indication:
- Asthma
- Pharmaceutical company
- Ranbaxy (UK) Ltd
- BNF chapter
- Respiratory system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 June 2007